Citigroup
C
$124.21
+1.59%
Citigroup is a global diversified financial institution operating across five core segments — Services (Treasury and Trade Solutions and Securities Services), Markets, Banking, Wealth, and U.S. Personal Banking — moving more than $6 trillion in daily transaction volume across a proprietary network spanning 94 countries and serving roughly 90% of the Fortune 500. Its competitive identity rests on that unmatched cross-border network, which makes it the connective tissue for multinational corporate cash management and trade finance rather than a pure domestic lender like peers, though it has historically traded at a discount to higher-returning rivals due to a more complex, capital-intensive footprint. The current investor narrative centers on the multi-year simplification and turnaround effort, with the most recent Q3 2026 print showing an earnings beat on higher net interest income and lower expenses alongside management's raised return outlook and AI-driven efficiency gains — yet the shares fell on the report as investors fixated on declining capital ratios and rising credit provisions. That tension between improving operating execution and balance-sheet/credit concerns, layered on a persistent valuation discount, is what frames the debate around Citigroup today.…
C
Citigroup
$124.21
Related headlines
Investment Opinion: Should I buy C Today?
Rating: Buy, with a staggered-entry discipline. The core thesis is that Citigroup trades at 1.00x book and 9.11x forward earnings while 18 of 21 analysts rate it Buy and the lowest published target ($127.00) sits 6.7% above the $119.05 price — a dislocation between price and fundamental expectations rather than a deterioration in the franchise. The $150.60 average target implies +26.5% upside, and the 2.53% dividend yield plus $3.0 billion of quarterly buybacks provide a tangible return floor while the turnaround plays out.
The supporting evidence is concrete: Q3 2026 revenue of $45.628 billion grew 4.07% YoY, net income of $5.245 billion rose 39.8% from $3.752 billion a year earlier, and operating margin expanded to 16.01% from 12.20% as AI and efficiency savings hit the P&L. The PEG of 0.81 and forward PE of 9.11x against consensus 2027 EPS of $18.30 imply the market is paying a discount for growth that is already being delivered, and the 37.6% payout ratio leaves ample room to sustain capital returns. The one blemish is cash flow — TTM FCF of -$1.724 billion — but that reflects working-capital and securities swings (Q3 alone generated +$22.27 billion) rather than structural weakness.
The biggest risks that could invalidate the thesis are (1) credit provisions continuing to climb and compressing net margin below the current 11.50%, (2) capital ratios declining further and forcing a cut to the $3.0 billion quarterly buyback, and (3) ROE of 6.74% failing to progress toward double digits, which would entrench the 1.0x book discount. This Buy would downgrade to Hold if net margin falls below 10% for two consecutive quarters or if the stock breaks decisively below the $118 support zone toward the $95.83 52-week low; it would upgrade in conviction if ROE crosses 8% with stable credit. Verdict: undervalued relative to its own forward earnings power and modestly undervalued versus a 1.5x-2.0x peer book multiple, though fairly valued on trailing 16.14x PE — the asymmetry favors patient accumulation, not a full position at once.
Sign up to view all
C 12-Month Price Forecast
The forward view is constructive but requires patience. Citigroup enters the next twelve months priced at 1.00x book and 9.11x forward earnings against consensus 2027 EPS of $18.30, a valuation that already discounts substantial skepticism about its 6.74% ROE and rising credit provisions. The operating trajectory is the swing factor: operating margin expanded to 16.01% from 12.20% and net income grew 39.8% YoY, showing the AI and efficiency program is producing real earnings leverage, while Services at $6.614 billion remains the durable growth engine. Analyst sentiment reinforces the skew — 18 Buy ratings, zero Sells, and a target range entirely above the current price — but the 34% spread between the $127.00 low and $170.00 high, plus the recent 11.81% three-month decline, argues for staggered entry rather than conviction sizing. I would upgrade to high confidence if Q4 shows net margin recovering above 12.87% with stable capital ratios; I would downgrade to neutral if provisions keep climbing and net margin falls below 10% for two consecutive quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Citigroup's 12-month outlook, with a consensus price target around $150.60 and implied upside of +21.2% versus the current price.
Average Target
$150.60
23 analysts
Implied Upside
+21.2%
vs. current price
Analyst Count
23
covering this stock
Price Range
$127 - $170
Analyst target range
Coverage is robust, with 21 analysts following Citigroup and a decidedly bullish tilt: 18 rate it Buy, 5 Hold, and 0 Sell, producing a consensus recommendation of "buy" and a recommendation mean of 1.65 (where 1.0 is a strong buy). The average target price of $150.60 implies roughly +26.5% upside from the current $119.05, and notably even the lowest target of $127.00 sits about 6.7% above the current price — meaning every published analyst target is above where the stock trades today, a strong signal that the selloff has outrun fundamental expectations. The consensus is clearly bullish, and the fact that the stock is trading below the entire target range suggests either a compelling dislocation or that estimates have yet to be revised down for the credit and capital concerns flagged in the Q3 report. The full target range spans $127.00 to $170.00, a spread of about 34% of the low end, which signals meaningful dispersion in conviction. The high target of $170.00 (roughly +42.8% upside) likely assumes successful execution of the turnaround — sustained Services growth, AI-driven expense savings, ROE expansion toward double digits, and multiple re-rating from 1.0x book toward peer levels — while the low target of $127.00 prices in a more cautious scenario of margin compression, elevated credit provisions, and capital-ratio pressure limiting buybacks. Institutional ratings show a stable-to-constructive pattern rather than fresh downgrades: JP Morgan reiterated Overweight on October 30, TD Cowen and RBC maintained Buy/Outperform on October 14, HSBC kept Buy on September 28, while UBS and Evercore ISI stayed Neutral/In Line — indicating the bulls are holding conviction through the pullback even as the neutral camp remains anchored on balance-sheet concerns. The combination of universal upside to targets, a 0.81 PEG, and 1.0x book makes the risk/reward skew favorable, though the wide target spread and recent price weakness argue for staggered entry rather than a single full position.
Bulls vs Bears: C Investment Factors
The bull case currently has the stronger evidence: a 1.0x book value, 9.11x forward PE, 0.81 PEG, universal analyst upside with a $127 floor target, and genuine margin expansion (16.01% operating margin versus 12.20% a year ago) all point to a dislocation rather than deterioration. The bear case rests on real but narrower concerns — rising credit provisions, declining capital ratios, and a 6.74% ROE that justifies some discount — amplified by negative momentum and an 18.69% drawdown. The single most important tension is whether the Q3 credit and capital signals are a temporary provisioning cycle or the start of a sustained deterioration; if provisions normalize and capital ratios stabilize, the re-rating toward peer book multiples is the dominant driver, but if credit costs keep climbing, the 1.0x book is a value trap rather than a floor. On balance, the weight of hard data — earnings growth, expense discipline, and a target range entirely above the current price — favors the bulls, with the caveat that the stock needs a catalyst to break its corrective trend.
Bullish
- Every analyst target sits above price: The lowest of 21 analyst targets is $127.00, already 6.7% above the $119.05 close, while the $150.60 average implies +26.5% upside. With 18 Buy ratings, 5 Hold and zero Sell (recommendation mean 1.65), the selloff has pushed the stock below the entire published target range.
- Deep discount at 1.0x book: Citigroup trades at 1.00x price-to-book and 9.11x forward PE against a PEG of 0.81, despite generating $5.245 billion of Q3 2026 net income. A franchise earning $20B+ annually with a 2.53% dividend yield is priced as if returns never normalize.
- Margins expanding on cost cuts: Q3 2026 operating margin reached 16.01% versus 12.20% a year earlier, and Q2 hit 17.72%, the best of the recent run. Net income of $5.245B compares with just $3.752B in Q3 2025, showing the AI and efficiency program is translating into real earnings leverage.
- Services franchise carrying growth: Revenue rose 4.07% YoY to $45.628 billion, with Services at $6.614 billion and Markets at $6.113 billion as the largest segments. The institutional cross-border network spanning 94 countries and serving 90% of the Fortune 500 is the durable growth engine of the turnaround.
Bearish
- Credit provisions and capital ratios spooking: Shares fell on an otherwise strong Q3 beat because investors focused on declining capital ratios and rising credit provisions. Sequential net income slipped from $5.831B in Q2 to $5.245B in Q3, and net margin fell from 12.87% to 11.50%, showing the credit cycle is starting to bite.
- Weak returns versus best-in-class peers: ROE of 6.74% and ROA of 0.71% remain far below premium banks like JPMorgan, which is why Citigroup trades at 1.0x book while peers command 1.5x-2.0x+. The discount is partly structural, not just sentiment.
- Negative and volatile free cash flow: TTM free cash flow is -$1.724 billion, with Q1 at -$23.288B and Q2 at -$25.630B before Q3's +$22.27B swing. That lumpiness limits confidence in the capital-return story if working-capital and securities swings persist.
- Momentum has rolled over: The stock is down 6.50% over one month and 11.81% over three months versus SPY's -4.99% and -4.91%, producing relative strength of -1.51 and -6.90. It sits at only 44.5% of its 52-week range and has failed repeatedly at the $140-$148 highs.
C Technical Analysis
Citigroup is in a choppy, range-bound consolidation rather than a clean trend: the stock is up 18.05% over the trailing year but only 0.29% year-to-date, and at $119.05 it sits at roughly 44.5% of its 52-week range of $95.83 to $147.96 — meaning it has surrendered most of its 2026 gains and is trading in the lower-middle half of the band. That positioning is neither a momentum breakout nor a deep-value falling knife; it reflects a market that has repeatedly failed to hold the $140–148 highs reached in June and August. The 18.69% max drawdown confirms a meaningful peak-to-trough retrenchment from those highs, and the failure to reclaim them keeps the intermediate trend tilted defensive. Short-term momentum is clearly negative and decelerating: the stock is down 6.50% over the past month and 11.81% over three months, versus a 4.99% and 4.91% decline for SPY, producing relative strength of -1.51 (1-month) and -6.90 (3-month). This creates a sharp divergence with the +18.05% one-year return and +8.46 one-year relative strength, signaling that the longer-term uptrend has rolled over into a corrective phase rather than a fresh leg higher. The 6-month change of -5.18% and YTD of +0.29% confirm the stock has gone nowhere for most of 2026, and the recent slide from ~$131 on October 12 to $118.45 on November 5 — a roughly 10% drop in under four weeks — points to distribution and deteriorating near-term conviction. Key levels are well defined: support sits at the 52-week low of $95.83, with the recent $118–120 zone acting as the first line of defense after the November 5 close of $118.45; resistance is the 52-week high of $147.96, with the $140–145 cluster (June–August highs) as the nearer ceiling. A decisive break below $118 would open the door toward the low-$100s and the $95.83 floor, while reclaiming $140 would be required to repair the trend. With a beta of 1.154, the stock is about 15% more volatile than the market — modestly elevated but not extreme — which argues for somewhat smaller position sizing and wider stops given the current 18.69% drawdown and thin short interest (short ratio of just 0.03, indicating little bearish conviction to squeeze).
Beta
1.15
1.15x market volatility
Max Drawdown
-18.7%
Largest decline past year
52-Week Range
$96-$148
Price range past year
Annual Return
+23.3%
Cumulative gain past year
| Period | C Return | S&P 500 |
|---|---|---|
| 1m | -5.8% | -2.4% |
| 3m | -10.5% | -2.3% |
| 6m | +0.6% | +2.8% |
| 1y | +23.3% | +11.3% |
| ytd | +4.6% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
C Fundamental Analysis
Revenue is growing at a steady but unspectacular pace: Q3 2026 revenue came in at $45.628 billion, up 4.07% year-over-year from $43.845 billion in Q3 2025, and the multi-quarter trajectory shows consistent expansion — $44.435 billion in Q1 2026, $45.302 billion in Q2, and $45.628 billion in Q3 — with each quarter above the corresponding 2025 period ($41.255B, $42.345B, $43.845B). The segment mix reveals where the growth engine sits: Services at $6.614 billion and Markets at $6.113 billion are the largest contributors, followed by U.S. Personal Banking at $4.664 billion, Personal Banking and Wealth Management at $3.269 billion, and Banking at $1.741 billion, underscoring that the institutional Services franchise — the crown jewel of the turnaround — is carrying the growth story. The 4.07% top-line growth is respectable for a mega-cap bank but not accelerating, which means the investment case leans more on expense discipline, capital return, and multiple re-rating than on rapid revenue expansion. Profitability is solid and improving: Q3 2026 net income was $5.245 billion with a net margin of 11.50% and gross margin of 46.59%, and the trend across 2026 shows net income of $5.785 billion (Q1), $5.831 billion (Q2), and $5.245 billion (Q3) — all well above the $3.752 billion earned in Q3 2025. Operating margin came in at 16.01% in Q3 2026 versus 12.20% a year earlier, and the Q2 2026 operating margin of 17.72% was the strongest of the recent run, indicating genuine margin expansion driven by the cost-reduction program and AI efficiencies management highlighted. That said, the sequential dip in Q3 net income and margin from Q2 reflects the rising credit provisions and softer capital ratios that spooked investors, and the 11.50% net margin, while healthy, remains below what best-in-class peers generate — leaving room for further improvement if the efficiency push continues. Balance-sheet and cash-flow metrics require careful reading for a bank: debt-to-equity stands at 3.37x with a total-debt-to-capitalization of 79.6%, high in absolute terms but typical for a globally systemic institution, while ROE of 6.74% and ROA of 0.71% are modest and below management's targeted return ambitions. Free cash flow is lumpy and negative on a trailing basis (-$1.724 billion TTM) due to working-capital and investment-securities swings — Q3 2026 alone generated +$22.27 billion in FCF and $23.777 billion in operating cash flow, but Q1 and Q2 were deeply negative (-$23.288B and -$25.630B) — so cash generation is volatile rather than structurally weak. Liquidity is thin on a current-ratio basis (0.48), again normal for a bank whose balance sheet is dominated by deposits and trading assets, and the company continues returning capital aggressively with $3.0 billion of buybacks and $1.474 billion of dividends in Q3 alone, supported by a 2.53% dividend yield and a conservative 37.6% payout ratio.
Quarterly Revenue
$45.6B
2026-09
Revenue YoY Growth
+4.1%
YoY Comparison
Gross Margin
46.6%
Latest Quarter
Free Cash Flow
$-1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is C Overvalued?
Because Citigroup is profitable (Q3 2026 net income of $5.245 billion), the PE ratio is the appropriate primary metric, and the picture is one of stark divergence: the trailing PE of 16.14x sits well above the forward PE of 9.11x, implying the market expects earnings to roughly double — consistent with consensus 2027 EPS estimates of $18.30 versus the current trailing EPS of $0.067 (a distorted figure reflecting the bank's low reported per-share earnings base). That enormous trailing-to-forward gap signals the market is pricing in substantial normalized earnings power and a re-rating if execution holds, and the PEG ratio of 0.81 (below 1.0) suggests the stock is inexpensive relative to expected growth. On a price-to-book basis, Citigroup trades at just 1.00x — essentially at tangible book — which for a diversified global bank is a deep-discount valuation that embeds significant skepticism about returns. Peer comparison is constrained by the absence of explicit industry-average multiples in the provided valuation data, but the internal evidence is telling: a P/B of 1.00x, PS of 1.26x, and forward PE of 9.11x are all consistent with Citigroup's long-standing discount to premium peers like JPMorgan, which trade at materially higher book multiples on superior ROE. The discount is partly justified — Citigroup's 6.74% ROE and 0.71% ROA lag best-in-class banks — but a 1.0x book multiple arguably over-penalizes a franchise generating $5+ billion in quarterly net income with a 2.53% dividend yield and an improving efficiency story, suggesting the valuation offers asymmetric upside if returns normalize. Historical context reinforces the value case: Citigroup's own PE has ranged from roughly 5.2x to 24.1x over the past several years, and the current trailing 16.14x sits in the middle of that band while the forward 9.11x is toward the lower end; its P/B of 1.00x is near the top of its recent 0.38x–1.12x range but still far below the 1.5x–2.0x+ levels seen in stronger banking cycles. The stock is therefore not at a historical extreme in either direction — it is priced for modest optimism on earnings recovery but still carries a structural discount, meaning the market is neither euphoric nor capitulating, and the re-rating opportunity depends on sustained ROE improvement and credit stability.
PE
16.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~13x
vs. Industry Avg
14.0x
Industry PE ~14.0x*
EV/EBITDA
23.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on credit quality and capital adequacy. Q3 2026 net income fell sequentially to $5.245 billion from $5.831 billion in Q2, net margin compressed from 12.87% to 11.50%, and investors sold the stock specifically on rising credit provisions and declining capital ratios. TTM free cash flow is -$1.724 billion, with Q1 and Q2 each burning more than $23 billion before Q3's +$22.27 billion swing, so cash generation is volatile rather than dependable. Leverage is high at 3.37x debt-to-equity and 79.6% total-debt-to-capitalization, and with ROE of just 6.74% and ROA of 0.71%, the company has limited buffer to absorb a credit downturn without further margin pressure. Market and competitive risks stem from the persistent valuation discount and sector sensitivity. Citigroup trades at 1.00x book versus 1.5x-2.0x+ for premium peers like JPMorgan, a gap justified by its lower returns but one that could widen if the turnaround stalls. The beta of 1.154 means roughly 15% more volatility than the market, and the stock has underperformed SPY by 6.90 points over three months and 7.54 points year-to-date, showing it is not a defensive holding in a risk-off tape. Recent news highlights the sector's credit anxiety — Flagstar's guidance cut and delayed profitability target signal rising credit risk across banks — and the Q3 report itself showed the market punishing capital-ratio concerns even on an earnings beat. The worst-case scenario is a credit cycle that forces provisions higher while capital ratios keep declining, curtailing the $3.0 billion quarterly buyback and pushing ROE further below target. In that chain, the stock would retest its 52-week low of $95.83, roughly -19.5% from the current $119.05, and a break below the $118 support zone would open the path toward the low-$100s. The 18.69% max drawdown already experienced shows this magnitude of loss is realistic, and the analyst low target of $127.00 would likely be revised down in such a scenario, meaning downside could extend beyond the current published range.
FAQ
The most severe risk is credit deterioration: Q3 2026 net income fell sequentially to $5.245 billion from $5.831 billion and net margin compressed to 11.50% from 12.87% as provisions rose, and peer stress like Flagstar's guidance cut signals broader bank credit anxiety. Second is capital adequacy — declining capital ratios could force a cut to the $3.0 billion quarterly buyback, removing a key support for per-share earnings and sentiment. Third is structural return weakness: ROE of 6.74% and ROA of 0.71% justify the 1.0x book discount versus peers, and if returns fail to progress the stock remains a value trap. Fourth is market sensitivity — beta of 1.154 amplifies risk-off moves, and the stock has already underperformed SPY by 6.90 points over three months and 7.54 points year-to-date, with TTM free cash flow of -$1.724 billion showing cash-generation volatility. Ranked by severity: credit, then capital/buyback, then ROE stagnation, then macro beta.
The 12-month outlook splits into three scenarios. The base case (55% probability) targets $127.00-$150.60, assuming revenue growth holds near 4.07%, margins stay in the 11-13% band, and the stock recovers toward the $150.60 analyst average while the 1.0x book and 9.11x forward PE provide a floor. The bull case (25%) targets $150.60-$170.00, requiring clean turnaround execution — Services and Markets growth, AI-driven expense savings, ROE toward 8-9%, and a re-rating to 1.2x-1.3x book. The bear case (20%) targets $95.83-$127.00, driven by a credit cycle that lifts provisions, curtails buybacks, and retests the 52-week low. The base case is most likely, and its key assumption is that the Q3 credit and capital signals prove a temporary provisioning cycle rather than sustained deterioration — if that holds, the valuation floor and capital returns deliver a mid-single-digit total return even without multiple expansion.
Citigroup screens as undervalued on the metrics that matter for a bank. It trades at 1.00x price-to-book — essentially tangible book — versus 1.5x-2.0x+ for premium peers like JPMorgan, and at 9.11x forward earnings against consensus 2027 EPS of $18.30, with a PEG of 0.81 that is below the 1.0 threshold typically marking fair growth-adjusted value. The trailing PE of 16.14x looks higher, but that gap versus the forward multiple reflects the market pricing in substantial normalized earnings power rather than a rich valuation. Historically, the 1.00x book sits near the top of its recent 0.38x-1.12x range but far below stronger-cycle levels, so the stock is neither at a euphoric extreme nor capitulating. The discount is partly earned given ROE of 6.74% and ROA of 0.71%, but a 1.0x multiple arguably over-penalizes a franchise generating $5.245 billion of quarterly net income — implying the market expects returns to stay depressed unless execution improves.
From a risk/reward standpoint, Citigroup offers an unusually favorable skew for a mega-cap bank: the average analyst target of $150.60 implies +26.5% upside, and even the lowest of 21 targets ($127.00) is 6.7% above the $119.05 price, meaning the stock trades below the entire published target range. The valuation support is real — 1.00x book, 9.11x forward PE, a 0.81 PEG, and a 2.53% dividend yield backed by a conservative 37.6% payout ratio. The biggest downside risk is a credit cycle that pushes provisions higher and forces a buyback cut, which could send shares to the $95.83 52-week low, roughly -19.5%. It is a good buy for patient, value-oriented investors who can stagger entries and hold through volatility (beta 1.154), but less suited to those needing near-term momentum, given the 11.81% three-month decline and relative underperformance versus SPY.
Citigroup is better suited to a long-term hold than a short-term trade. It is a mid-stage turnaround in a mature, capital-intensive industry: revenue is growing a steady but unspectacular 4.07%, earnings visibility is decent but credit-sensitive, and the thesis depends on ROE normalization and multiple re-rating that play out over multiple quarters, not weeks. The 2.53% dividend yield and roughly $3.0 billion of quarterly buybacks reward patience, while beta of 1.154, an 18.69% max drawdown, and an 11.81% three-month decline make it a poor vehicle for momentum traders. Short interest is negligible (short ratio 0.03), so there is no squeeze catalyst either. A suggested minimum holding period is 12-24 months, entered in tranches, with a review trigger if net margin falls below 10% for two consecutive quarters or the stock breaks decisively below $118.